We observed a significant decline in anti-PF4/P antibody levels in convalescent patients, like what is observed in patients with HIT, VITT, or COVID-19, in whom antibody levels are transiently and acutely elevated under antigen exposure and inflammatory conditions, with a rapid decline in recovery (26). The gene discussed is PF4; the disease is COVID-19.